6 results
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... isolate DST result should ... Tuberculosis #MDRTB #management ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
brain PRES Clinical ... may precede the neurologic ... on MRA/CTA • Anterior ... count in the CSF should ... #management #neurology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
and molecular diagnostic ... empiric treatment should ... HIV-infected persons with clinical ... #Treatment #management ... infections #HIVAIDS #pharmacology
Transverse Myelitis Overview

Focal inflammatory disorder of the spinal cord resulting in rapid onset of weakness, sensory
Transverse Myelitis - Clinical ... NMO-IgG (anti-AQP4) should ... , MOG-IgG test should ... , Hep A/B/CMV, TB ... #management #neurology
Anti-NXP-2 Dermatomyositis

What?
DM with generalized subcutaneous edema
Pts have more myalgias, more severe weakness, and an increased prevalence
the face, or the anterior ... , and back and shoulders ... auricular papules Clinical ... three days #AntiNXP2DM ... #diagnosis #management
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
disease based on clinical ... Note: Active TB ... should be ruled ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology